{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:32:00Z","timestamp":1791869520260,"version":"4.3.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study used an atrial septal shunt to compare the treatment progress and prognosis for patients with heart failure (HF) who have different ejection fractions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Twenty HF patients with pulmonary hypertension, who required atrial septal shunt therapy, were included in this study. The patients underwent surgery between December 2012 and December 2020. They were divided into two groups based on their ejection fraction: a group with reduced ejection fraction (HFrEF) and a group with preserved ejection fraction(HFpEF) + mid-range ejection fraction (HfmrEF). Echocardiography was utilized to evaluate parameters such as left ventricular dimension (LVD), left ventricular ejection fraction (LVEF), and left ventricular end-diastolic volume (LVEDV). Hemodynamic parameters were measured using cardiac catheterization. The patient's cardiac function was assessed using the six-minute walking test (6MWT), KCCQ score, NYHA classification, and the degree of\u00a0functional mitral regurgitation\u00a0(FMR). Followed-up visits were conducted at 1, 3, and 6\u00a0months, and any adverse effects were recorded.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The LVEF values were consistently higher in the HFpEF+HFmrEF group than HFrEF group at all periods (<jats:italic>P\u2009<\/jats:italic>&lt;\u20090.05). Differences in LVD were observed between the two groups before the surgery. Statistically, significant differences were found at the preoperative stage, 1 month, and 3 months (<jats:italic>P\u2009<\/jats:italic>&lt;\u20090.05, respectively). However, the LVEDV showed a significant difference between the two groups only at 3 months (<jats:italic>P\u2009<\/jats:italic>=\u20090.049). Notably, there were notable variations in LAPm, LAPs, and the pressure gradient between the LA-RA gradient at baeline, after implantation, and during the 6\u00a0months follow-up (all <jats:italic>P\u2009<\/jats:italic>&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Following treatment, the HFpEF+HFmrEF group exhibited more significant improvements in echocardiographic and cardiac catheterization indices than the HFrEF group. However, there was no statistically significant difference between the two groups regarding the 6MWT and KCCQ scores. It is important to note that the findings of this study still require further investigation in a large sample size of patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13019-023-02398-9","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T07:02:02Z","timestamp":1700031722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Short-term study of atrial shunt and improvement of functional mitral regurgitation"],"prefix":"10.1186","volume":"18","author":[{"given":"Xiaoke","family":"Shang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changdong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianguo","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"issue":"4","key":"2398_CR1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.hfc.2019.06.007","volume":"15","author":"J Slivnick","year":"2019","unstructured":"Slivnick J, Lampert BC. Hypertension and heart failure. Heart Fail Clin. 2019;15(4):531\u201341.","journal-title":"Heart Fail Clin"},{"issue":"2","key":"2398_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.tcm.2019.03.007","volume":"30","author":"L Sinnenberg","year":"2020","unstructured":"Sinnenberg L, Givertz MM. Acute heart failure. Trends Cardiovasc Med. 2020;30(2):104\u201312.","journal-title":"Trends Cardiovasc Med"},{"key":"2398_CR3","doi-asserted-by":"crossref","unstructured":"Gali\u00e8 N, McLaughlin VV, Rubin LJ, Simonneau G. An overview of the 6th World Symposium on Pulmonary Hypertension. Eur Respir J. 2019, 53(1).","DOI":"10.1183\/13993003.02148-2018"},{"key":"2398_CR4","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.18811.1","author":"DF Condon","year":"2019","unstructured":"Condon DF, Nickel NP, Anderson R, Mirza S, de Jesus Perez VA. The world symposium on pulmonary hypertension: what\u2019s old is new. F1000Research. 2019. https:\/\/doi.org\/10.12688\/f1000research.18811.1.","journal-title":"F1000Research"},{"key":"2398_CR5","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1146\/annurev-physiol-031620-123956","volume":"83","author":"W Xu","year":"2021","unstructured":"Xu W, Janocha AJ, Erzurum SC. Metabolism in pulmonary hypertension. Annu Rev Physiol. 2021;83:551\u201376.","journal-title":"Annu Rev Physiol"},{"issue":"4","key":"2398_CR6","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s11845-017-1597-9","volume":"186","author":"C Murphy","year":"2017","unstructured":"Murphy C, Zafar H, Sharif F. An updated review of cardiac devices in heart failure. Ir J Med Sci. 2017;186(4):909\u201319.","journal-title":"Ir J Med Sci"},{"issue":"4","key":"2398_CR7","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.amjcard.2016.05.050","volume":"118","author":"JW Schleifer","year":"2016","unstructured":"Schleifer JW, Mookadam F, Kransdorf EP, Nanda U, Adams JC, Cha S, Pajaro OE, Steidley DE, Scott RL, Carvajal T. Effect of continued cardiac resynchronization therapy on ventricular arrhythmias after left ventricular assist device implantation. Am J Cardiol. 2016;118(4):556\u20139.","journal-title":"Am J Cardiol"},{"key":"2398_CR8","doi-asserted-by":"crossref","unstructured":"Lin A, Ho G. Cardiac resynchronization therapy in patients with left ventricular assist devices. In: Case-based device therapy for heart failure. Springer; 2021. p. 337\u201341.","DOI":"10.1007\/978-3-030-70038-6_22"},{"issue":"4","key":"2398_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jchf.2019.11.006","volume":"8","author":"EP Zeitler","year":"2020","unstructured":"Zeitler EP, Abraham WT. Novel devices in heart failure: BAT, atrial shunts, and phrenic nerve stimulation. JACC Heart Fail. 2020;8(4):251\u201364.","journal-title":"JACC Heart Fail"},{"issue":"5","key":"2398_CR10","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/ejhf.2119","volume":"23","author":"C Paitazoglou","year":"2021","unstructured":"Paitazoglou C, Bergmann MW, \u00d6zdemir R, Pfister R, Bartunek J, Kilic T, Lauten A, Schmeisser A, Zoghi M, Anker SD. One-year results of the first-in-man study investigating the atrial flow regulator for left atrial shunting in symptomatic heart failure patients: the PRELIEVE study. Eur J Heart Fail. 2021;23(5):800\u201310.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"2398_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.21693\/1933-088X-18.1.4","volume":"18","author":"V Kaley","year":"2019","unstructured":"Kaley V, Dahdah N, El-Sisi A, Grohmann J, Rosenthal E, Jones M, Morgan G, Hayes N, Shah A, Karakurt C. Atrial septal defect\u2013associated pulmonary hypertension: outcomes of closure with a fenestrated device. Adv Pulm Hypertens. 2019;18(1):4\u20139.","journal-title":"Adv Pulm Hypertens"},{"key":"2398_CR12","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1183\/16000617.0099-2020","volume":"29","author":"S Akseer","year":"2020","unstructured":"Akseer S, Horlick E, Vishwanath V, Hobbes B, Huszti E, Mak S, Lee DS, Abrahamyan L. Prevalence and outcomes of pulmonary hypertension after percutaneous closure of atrial septal defect: a systematic review and meta-analysis. Eur Respir Rev. 2020;29:158.","journal-title":"Eur Respir Rev"},{"issue":"10","key":"2398_CR13","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.jcin.2020.02.022","volume":"13","author":"S Trevor","year":"2020","unstructured":"Trevor S, Marino L, Firas Z, Babak N, William G, James H, Sunit-Preet C, Leonardo G, Franois P, Peter E. Percutaneous atriotomy for levoatrial-to-coronary sinus shunting insymptomatic heartfailure: first-in-human experience. JACC Cardiovasc Interv. 2020;13(10):1236\u201347.","journal-title":"JACC Cardiovasc Interv"},{"key":"2398_CR14","doi-asserted-by":"crossref","unstructured":"Shang X, Liu M, Zhong Y, Wang X, Chen S, Fu X, Sun M, Xie M, Ke Y, Guan Y. Clinical study on the treatment of chronic heart failure with a novel D\u2010shant atrium shunt device. ESC Heart Fail. 2022.","DOI":"10.1002\/ehf2.13842"},{"issue":"17","key":"2398_CR15","doi-asserted-by":"publisher","first-page":"e016760","DOI":"10.1161\/JAHA.120.016760","volume":"9","author":"JM Griffin","year":"2020","unstructured":"Griffin JM, Borlaug BA, Komtebedde J, Litwin SE, Shah SJ, Kaye DM, Hoendermis E, Hasenfu\u00df G, Gustafsson F, Wolsk E. Impact of interatrial shunts on invasive hemodynamics and exercise tolerance in patients with heart failure. J Am Heart Assoc. 2020;9(17):e016760.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"2398_CR16","first-page":"281","volume":"28","author":"S Nanayakkara","year":"2023","unstructured":"Nanayakkara S, Kaye DM. Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction. Heart Fail Rev. 2023;28(2):281\u20136.","journal-title":"Heart Fail Rev"},{"issue":"1","key":"2398_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Gali\u00e8","year":"2016","unstructured":"Gali\u00e8 N, Humbert M, Vachiery J-L, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M. 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67\u2013119.","journal-title":"Eur Heart J"},{"issue":"6","key":"2398_CR18","doi-asserted-by":"publisher","first-page":"E830","DOI":"10.1002\/ccd.29590","volume":"97","author":"E Vanhie","year":"2021","unstructured":"Vanhie E, VandeKerckhove K, Haas NA, De Wolf D. Atrial flow regulator for drug-resistant pulmonary hypertension in a young child. Catheter Cardiovasc Interv. 2021;97(6):E830\u20134.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"2398_CR19","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ehf2.13114","volume":"8","author":"D Huang","year":"2021","unstructured":"Huang D, Hua W, Fang Q, Yan J, Su Y, Liu B, Xu Y, Peng Y, Investigators PC. Biventricular pacemaker and defibrillator implantation in patients with chronic heart failure in China. ESC Heart Fail. 2021;8(1):546\u201354.","journal-title":"ESC Heart Fail"},{"issue":"5","key":"2398_CR20","doi-asserted-by":"publisher","first-page":"e023724","DOI":"10.1136\/bmjopen-2018-023724","volume":"9","author":"F Meng","year":"2019","unstructured":"Meng F, Zhang Z, Hou X, Qian Z, Wang Y, Chen Y, Wang Y, Zhou Y, Chen Z, Zhang X. Machine learning for prediction of sudden cardiac death in heart failure patients with low left ventricular ejection fraction: study protocol for a retroprospective multicentre registry in China. BMJ Open. 2019;9(5):e023724.","journal-title":"BMJ Open"},{"issue":"12","key":"2398_CR21","doi-asserted-by":"publisher","first-page":"e003662","DOI":"10.1161\/CIRCHEARTFAILURE.116.003662","volume":"9","author":"DM Kaye","year":"2016","unstructured":"Kaye DM, Hasenfuss G, Neuzil P, Post MC, Doughty R, Trochu J-N, Kolodziej A, Westenfeld R, Penicka M, Rosenberg M. One-year outcomes after transcatheter insertion of an interatrial shunt device for the management of heart failure with preserved ejection fraction. Circul Heart Fail. 2016;9(12):e003662.","journal-title":"Circul Heart Fail"},{"issue":"20","key":"2398_CR22","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","volume":"382","author":"PW Armstrong","year":"2020","unstructured":"Armstrong PW, Pieske B, Anstrom KJ, Ezekowitz J, Hernandez AF, Butler J, Lam CS, Ponikowski P, Voors AA, Jia G. Vericiguat in patients with heart failure and reduced ejection fraction. N Engl J Med. 2020;382(20):1883\u201393.","journal-title":"N Engl J Med"},{"issue":"2","key":"2398_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/clc.23321","volume":"43","author":"B Upadhya","year":"2020","unstructured":"Upadhya B, Kitzman DW. Heart failure with preserved ejection fraction: new approaches to diagnosis and management. Clin Cardiol. 2020;43(2):145\u201355.","journal-title":"Clin Cardiol"},{"key":"2398_CR24","doi-asserted-by":"crossref","first-page":"175394471987008","DOI":"10.1177\/1753944719870084","volume":"13","author":"S Giannitsi","year":"2019","unstructured":"Giannitsi S, Bougiakli M, Bechlioulis A, Kotsia A, Michalis LK, Naka KK. 6-minute walking test: a useful tool in the management of heart failure patients. Therap Adv Cardiovasc Dis. 2019;13:1753944719870084.","journal-title":"Therap Adv Cardiovasc Dis"},{"issue":"1","key":"2398_CR25","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s12955-020-01604-9","volume":"18","author":"R Capota","year":"2020","unstructured":"Capota R, Militaru S, Ionescu AA, Rosca M, Jurcut R. Quality of life status determinants in hypertrophic cardiomyopathy as evaluated by the Kansas City Cardiomyopathy Questionnaire. Health Qual Life Outcomes. 2020;18(1):351.","journal-title":"Health Qual Life Outcomes"},{"issue":"11","key":"2398_CR26","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1016\/j.jcmg.2022.08.016","volume":"15","author":"WA Zoghbi","year":"2022","unstructured":"Zoghbi WA, Levine RA, Flachskampf F, Grayburn P, Gillam L, Leipsic J, Thomas JD, Kwong RY, Vandervoort P, Chandrashekhar Y. Atrial functional mitral regurgitation: a JACC: cardiovascular imaging expert panel viewpoint. JACC Cardiovasc Imaging. 2022;15(11):1870\u201382.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"2398_CR27","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0735-1097(00)00531-3","volume":"35","author":"CP Green","year":"2000","unstructured":"Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000;35(5):1245\u201355.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2398_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1177\/1474515111435605","volume":"11","author":"RM Creber","year":"2012","unstructured":"Creber RM, Polomano R, Farrar J, Riegel B. Psychometric properties of the Kansas City cardiomyopathy questionnaire (KCCQ). Eur J Cardiovasc Nurs. 2012;11(2):197\u2013206.","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"15","key":"2398_CR29","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa1009355","volume":"364","author":"T Feldman","year":"2011","unstructured":"Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, Smalling RW, Siegel R, Rose GA, Engeron E. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364(15):1395\u2013406.","journal-title":"N Engl J Med"},{"issue":"12","key":"2398_CR30","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1080\/14767058.2018.1536740","volume":"33","author":"N Nakwan","year":"2020","unstructured":"Nakwan N, Jain S, Kumar K, Hosono S, Hammoud M, Elsayed YY, Ariff S, Hasan B, Khowaja W, Poon WB. An Asian multicenter retrospective study on persistent pulmonary hypertension of the newborn: incidence, etiology, diagnosis, treatment and outcome. J Matern Fetal Neonatal Med. 2020;33(12):2032\u20137.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"4","key":"2398_CR31","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1161\/CIRCRESAHA.118.314555","volume":"125","author":"B Ranchoux","year":"2019","unstructured":"Ranchoux B, Nadeau V, Bourgeois A, Provencher S, Tremblay \u00c9, Omura J, Cot\u00e9 N, et al. Metabolic syndrome exacerbates pulmonary hypertension due to left heart disease. Circ Res. 2019;125(4):449\u201366.","journal-title":"Circ Res"},{"key":"2398_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ijcard.2018.08.078","volume":"272","author":"H Kaemmerer","year":"2018","unstructured":"Kaemmerer H, Apitz C, Brockmeier K, Eicken A, Gorenflo M, Hager A, de Haan F, Huntgeburth M, Kozlik-Feldmann RG, Miera O. Pulmonary hypertension in adults with congenital heart disease: updated recommendations from the Cologne Consensus Conference 2018. Int J Cardiol. 2018;272:79\u201388.","journal-title":"Int J Cardiol"},{"issue":"9","key":"2398_CR33","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/0002-9149(83)90678-1","volume":"51","author":"S Rich","year":"1983","unstructured":"Rich S, Lam W. Atrial septostomy as palliative therapy for refractory primary pulmonary hypertension. Am J Cardiol. 1983;51(9):1560\u20131.","journal-title":"Am J Cardiol"},{"issue":"3","key":"2398_CR34","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0002-9149(97)00370-6","volume":"80","author":"S Rich","year":"1997","unstructured":"Rich S, Dodin E, McLaughlin VV. Usefulness of atrial septostomy as a treatment for primary pulmonary hypertension and guidelines for its application. Am J Cardiol. 1997;80(3):369\u201371.","journal-title":"Am J Cardiol"},{"issue":"4","key":"2398_CR35","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/ccd.21216","volume":"70","author":"AE Lammers","year":"2007","unstructured":"Lammers AE, Derrick G, Haworth SG, Bonhoeffer P, Yates R. Efficacy and long-term patency of fenestrated amplatzer devices in children. Catheter Cardiovasc Interv. 2007;70(4):578\u201384.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"7","key":"2398_CR36","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1161\/01.CIR.91.7.2028","volume":"91","author":"D Kerstein","year":"1995","unstructured":"Kerstein D, Levy PS, Hsu DT, Hordof AJ, Gersony WM, Barst RJ. Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension. Circulation. 1995;91(7):2028\u201335.","journal-title":"Circulation"},{"issue":"1","key":"2398_CR37","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1540-8183.2012.00759.x","volume":"26","author":"R Baglini","year":"2013","unstructured":"Baglini R. Atrial septostomy in patients with end-stage pulmonary hypertension. No more needles but wires, energy and close anatomical definition. J Interv Cardiol. 2013;26(1):62\u20138.","journal-title":"J Interv Cardiol"},{"issue":"21","key":"2398_CR38","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1016\/j.jacc.2019.08.1062","volume":"74","author":"M Obokata","year":"2019","unstructured":"Obokata M, Reddy YN, Shah SJ, Kaye DM, Gustafsson F, Hasenfu\u03b2 G, Hoendermis E, Litwin SE, Komtebedde J, Lam C. Effects of interatrial shunt on pulmonary vascular function in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2019;74(21):2539\u201350.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2398_CR39","first-page":"11278","volume":"10","author":"IJ Amat-Santos","year":"2015","unstructured":"Amat-Santos IJ, Bergeron S, Bernier M, Allende R, Ribeiro HB, Urena M, Pibarot P, Verheye S, Keren G, Yaacoby M. Left atrial decompression through unidirectional left-to-right interatrial shunt for the treatment of left heart failure: first-in-man experience with the V-Wave device. EuroInterv J EuroPCR Collab Work Group Interv Cardiol Eur Soc Cardiol. 2015;10(9):11278.","journal-title":"EuroInterv J EuroPCR Collab Work Group Interv Cardiol Eur Soc Cardiol"},{"key":"2398_CR40","doi-asserted-by":"crossref","unstructured":"Patel MB, Samuel BP, Girgis RE, Parlmer MA, Vettukattil JJ. 13. Implantable atrial flow regulator for severe irreversible pulmonary arterial hypertension. In: Pediatric and adult interventional cardiac symposium: 2015; 2015.","DOI":"10.4244\/EIJY15M07_08"},{"issue":"24","key":"2398_CR41","doi-asserted-by":"publisher","first-page":"15153","DOI":"10.1021\/acs.jmedchem.0c01093","volume":"63","author":"W Zheng","year":"2020","unstructured":"Zheng W, Wang Z, Jiang X, Zhao Q, Shen J. Targeted drugs for treatment of pulmonary arterial hypertension: past, present, and future perspectives. J Med Chem. 2020;63(24):15153\u201386.","journal-title":"J Med Chem"},{"issue":"5","key":"2398_CR42","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1136\/hrt.55.5.449","volume":"55","author":"A Rozkovec","year":"1986","unstructured":"Rozkovec A, Montanes P, Oakley C. Factors that influence the outcome of primary pulmonary hypertension. Heart. 1986;55(5):449\u201358.","journal-title":"Heart"},{"key":"2398_CR43","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2147\/MDER.S113105","volume":"10","author":"JJ Cuthbert","year":"2017","unstructured":"Cuthbert JJ, Pellicori P, Clark AL. Interatrial shunt devices for heart failure with normal ejection fraction: a technology update. Medical Devices. 2017;10:123.","journal-title":"Medical Devices"},{"issue":"7","key":"2398_CR44","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1136\/hrt.2005.077669","volume":"92","author":"A Micheletti","year":"2006","unstructured":"Micheletti A, Hislop A, Lammers A, Bonhoeffer P, Derrick G, Rees P, Haworth SG. Role of atrial septostomy in the treatment of children with pulmonary arterial hypertension. Heart. 2006;92(7):969\u201372.","journal-title":"Heart"},{"issue":"7","key":"2398_CR45","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/ccd.27233","volume":"90","author":"R Rajeshkumar","year":"2017","unstructured":"Rajeshkumar R, Pavithran S, Sivakumar K, Vettukattil JJ. Atrial septostomy with a predefined diameter using a novel occlutech atrial flow regulator improves symptoms and cardiac index in patients with severe pulmonary arterial hypertension. Catheter Cardiovasc Interv. 2017;90(7):1145\u201353.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"3","key":"2398_CR46","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1161\/CIRCHEARTFAILURE.110.959890","volume":"4","author":"M Haass","year":"2011","unstructured":"Haass M, Kitzman DW, Anand IS, Miller A, Zile MR, Massie BM, Carson PE. Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circul Heart Fail. 2011;4(3):324\u201331.","journal-title":"Circul Heart Fail"},{"issue":"3","key":"2398_CR47","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0735-1097(01)01448-6","volume":"38","author":"TB Horwich","year":"2001","unstructured":"Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol. 2001;38(3):789\u201395.","journal-title":"J Am Coll Cardiol"},{"key":"2398_CR48","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2147\/IJGM.S251924","volume":"13","author":"AH Subki","year":"2020","unstructured":"Subki AH, Almalki M, Butt NS, Alsallum MS, Alghalayini KW. Echocardiographic and clinical correlates of ejection fraction among 2000 patients with heart failure in Western Saudi Arabia. Int J Gener Med. 2020;13:281\u20138.","journal-title":"Int J Gener Med"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-023-02398-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-023-02398-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-023-02398-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T08:04:15Z","timestamp":1700035455000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-023-02398-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2398"],"URL":"https:\/\/doi.org\/10.1186\/s13019-023-02398-9","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]},"assertion":[{"value":"31 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of Wuhan Union Hospital approved the study protocol. Informed consent was obtained from all the study subjects before enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"332"}}